DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sun Pharma Advanced Research Company Limited — Outcome of Board Meeting

NSE 4 hrs ago·10 Aug 2026, 8:04 am

Sun Pharma Advanced Research Company

Sun Pharma Advanced Research Company Limited (SPARC) has announced its unaudited financial results for the quarter that ended on June 30, 2026. The company has submitted these results to the stock exchange, marking the official disclosure of its performance during this period.

For investors, this update is significant as it provides a snapshot of SPARC's operational health and financial standing. It allows stakeholders to track the company's progress and assess its performance against previous periods.

Investors should look closely at the specific metrics within the results, such as revenue growth, profit margins, and cash flow. Monitoring these figures will help gauge the company's current trajectory and future potential.